Skip to main content
Contact Us
Subscribe
E-Edition
70°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Alimera Sciences Inc
(NQ:
ALIM
)
5.590
+0.010 (+0.18%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Alimera Sciences Inc
< Previous
1
2
Next >
ALIM Stock Earnings: Alimera Sciences Misses EPS, Beats Revenue for Q2 2024
August 06, 2024
ALIM stock results show that Alimera Sciences missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Nasdaq Records Worst Session Since April With Nvidia Plunging 7%: Dow Jones Sees Modest Gains Amid Mixed Market Close
June 25, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Dow Jumps 300 Points; Alimera Sciences Shares Spike Higher
June 24, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is MicroAlgo (MLGO) Stock Up 113% Today?
June 24, 2024
MicroAlgo stock is up on Monday after the company revealed in an SEC filing that an investor now holds an almost 14% stake in MLGO.
Via
InvestorPlace
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Why Is Alimera Sciences (ALIM) Stock Up 77% Today?
June 24, 2024
Alimera Sciences stock is up on Monday as investors react to a $5.50 per share acquisition offer for ALIM from ANI Pharmaceuticals.
Via
InvestorPlace
A Preview Of Alimera Sciences's Earnings
March 06, 2024
Via
Benzinga
The Latest Analyst Ratings for Alimera Sciences
August 14, 2023
Via
Benzinga
Preview: Alimera Sciences's Earnings
August 09, 2023
Via
Benzinga
Alliance Global Partners Upgrades Alimera Sciences: Here's What You Need To Know
June 12, 2023
Via
Benzinga
Generics Player ANI Pharmaceuticals Strengthens Rare Disease Segment With $380M Alimera Sciences Deal
June 24, 2024
ANI Pharmaceuticals to acquire Alimera Sciences for $5.50 per share in cash, plus a contingent value right of up to $0.50 per share. The transaction is valued at $381 million and is expected to close...
Via
Benzinga
ALIM Stock Earnings: Alimera Sciences Misses EPS, Beats Revenue for Q1 2024
May 14, 2024
ALIM stock results show that Alimera Sciences missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
ALIM Stock Earnings: Alimera Sciences Beats Revenue for Q4 2023
March 07, 2024
ALIM stock results show that Alimera Sciences beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For June 12, 2023
June 12, 2023
Via
Benzinga
Expert Ratings for Alimera Sciences
June 12, 2023
Via
Benzinga
4 Analysts Have This to Say About Alimera Sciences
May 19, 2023
Via
Benzinga
Earnings Outlook For Alimera Sciences
March 30, 2023
Via
Benzinga
Earnings Scheduled For March 7, 2024
March 07, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.
Via
Benzinga
10 Short Squeeze Stocks To Watch: Getty Images, Intuitive Machines, Wearable Devices & More
June 12, 2023
Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a focus of new traders looking for the next huge move. High short interest and steep borrowing costs are among...
Via
Benzinga
Why Foot Locker Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 19, 2023
Gainers Monogram Orthopaedics Inc. (NASDAQ: MGRM) shares climbed 148.3% to $29.18 after jumping 62% on Thursday. Monogram Orthopaedics raised $17,216,147 through the sale of 2,374,641 shares of its...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 19, 2023
Via
Benzinga
Why DXC Technology Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarket
May 19, 2023
Gainers Monogram Orthopaedics Inc. (NASDAQ: MGRM) shares surged 163.7% to $30.98 in pre-market trading after jumping 62% on Thursday. Monogram Orthopaedics raised $17,216,147 through the sale of...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
May 19, 2023
It's time to start off the final day of the trading week with a breakdown of the biggest pre-market stock movers for Friday!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
May 18, 2023
Via
Benzinga
Why Monro Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
May 18, 2023
Gainers CaliberCos Inc. (NASDAQ: CWD) shares jumped 65.6% to $9.94 amid post-IPO volatility.
Via
Benzinga
Why Is Alimera Sciences (ALIM) Stock Up 21% Today?
May 18, 2023
Alimera Sciences (ALIM) stock is taking off on Thursday after signing a major deal with EyePoint Pharmaceuticals (EYPT).
Via
InvestorPlace
US Stocks Mixed; Jobless Claims Drop More than Projected
May 18, 2023
U.S. stocks traded mixed this morning, with the Dow Jones dropping around 100 points on Thursday. Following the market opening Thursday, the Dow traded down 0.31% to 33,315.53 while the NASDAQ rose...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 18, 2023
Via
Benzinga
EyePoint Pharma Offloads Its Commercially-Available Eye Implant For $82.5M Plus Royalties
May 18, 2023
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) has agreed to sell Yutiq (fluocinolone acetonide intravitreal implant) 0.18mg to Alimera Sciences Inc (NASDAQ: ALIM).
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
March 27, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
February 28, 2023
During Tuesday, 79 stocks hit new 52-week lows.
Via
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.